Suppr超能文献

组蛋白变体 H3.3 调控乙型肝炎病毒的转录。

The histone variant H3.3 regulates the transcription of the hepatitis B virus.

机构信息

Fundación Ciencia & Vida, Avenida Zañartu 1482, Ñuñoa, 7780272, Santiago, Chile.

Centro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad, San Sebastián, Santiago, 7510157, Chile.

出版信息

Ann Hepatol. 2021 Mar-Apr;21:100261. doi: 10.1016/j.aohep.2020.09.005. Epub 2020 Sep 29.

Abstract

INTRODUCTION AND OBJECTIVES

About 250 million people around the world are chronically infected with the hepatitis B virus (HBV). Those people are at risk of developing hepatocellular carcinoma. The HBV genome is organized as a minichromosome in the infected hepatocyte and is associated with histones and non-histone proteins. In recent years, many groups have investigated the transcriptional regulation of HBV mediated by post-translational modifications on the histones associated with the covalently closed circular DNA (cccDNA). Our aim is to investigate the role of the histone variant H3.3.

MATERIALS AND METHODS

An in vitro HBV replication model system based on the transfection of linear HBV genome monomeric molecules was used. We then either ectopically expressed or reduced the levels of H3.3, and of its histone chaperone HIRA. Viral intermediates were quantified and the level of H3K4me3 using Chromatin immunoprecipitation (ChIP) assay was measured.

RESULTS

Histone variant H3.3 ectopically expressed in cells assembles into the viral cccDNA, correlating with increasing levels of the active histone mark H3K4me3 and HBV transcription. The opposite results were found upon diminishing H3.3 levels. Furthermore, the assembly of H3.3 into the cccDNA is dependent on the histone chaperone HIRA. Diminishing HIRA levels causes a reduction in the HBV intermediates.

CONCLUSIONS

Histone variant H3.3 positively regulates HBV transcription. Importantly, the characterization of the viral chromatin dynamics might allow the discovery of new therapeutic targets to develop drugs for the treatment of chronically-infected HBV patients.

摘要

简介和目的

全球约有 2.5 亿人慢性感染乙型肝炎病毒(HBV)。这些人有发展为肝细胞癌的风险。HBV 基因组作为感染肝细胞中的微染色体组织,并与组蛋白和非组蛋白蛋白相关联。近年来,许多研究小组研究了与共价闭合环状 DNA(cccDNA)相关的组蛋白的翻译后修饰介导的 HBV 的转录调控。我们的目的是研究组蛋白变体 H3.3 的作用。

材料和方法

使用基于转染线性 HBV 基因组单体分子的体外 HBV 复制模型系统。然后我们异位表达或降低 H3.3 及其组蛋白伴侣 HIRA 的水平。定量病毒中间体,并使用染色质免疫沉淀(ChIP)测定测量 H3K4me3 水平。

结果

在细胞中异位表达的组蛋白变体 H3.3 组装到病毒 cccDNA 中,与活性组蛋白标记 H3K4me3 和 HBV 转录水平的增加相关。当降低 H3.3 水平时,得到了相反的结果。此外,H3.3 组装到 cccDNA 依赖于组蛋白伴侣 HIRA。降低 HIRA 水平会导致 HBV 中间体减少。

结论

组蛋白变体 H3.3 正向调节 HBV 转录。重要的是,对病毒染色质动力学的表征可能会发现新的治疗靶点,从而为治疗慢性感染 HBV 的患者开发药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验